Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,795 public trials 654 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine

NCT05107115

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Investigational Site Number : 0320006 CABA, Buenos Aires, Argentina
  • Investigational Site Number :0320006 CABA, Buenos Aires, Argentina
  • Investigational Site Number : 0320002 CABA, Buenos Aires, Argentina
  • Investigational Site Number :0320002 CABA, Buenos Aires, Argentina
View all 128 locations
View Trial Details
Completed

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

NCT03952559

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Instituto de Neumonología Y Dermatología Capital Federal, Buenos Aires, Argentina
  • Centro de Investigaciones Metabólicas (CINME) Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • Fundacion CIDEA Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina
  • Fundación Respirar Buenos Aires, Argentina
View all 78 locations
View Trial Details
Completed

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

NCT06467084

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Birmingham, Alabama, United States
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site San Diego, California, United States
  • KalVista Investigative Site Santa Monica, California, United States
View all 24 locations
View Trial Details
Completed

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

NCT05958407

Conditions
Atopic Dermatitis, Atopic Hand Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • LEO Pharma Investigational Site Birmingham, Alabama, United States
  • LEO Pharma Investigational Site Fort Smith, Arkansas, United States
  • LEO Pharma Investigational Site Fountain Valley, California, United States
  • LEO Pharma Investigational Site Los Angeles, California, United States
View all 69 locations
View Trial Details
Completed

Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old

NCT06290102

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12010 Mobile, Alabama, United States
  • Teva Investigational Site 12003 Long Beach, California, United States
  • Teva Investigational Site 12007 Miami, Florida, United States
  • Teva Investigational Site 12005 Miami, Florida, United States
View Trial Details

Related conditions